4.8 Article

Cap-independent translation and a precisely located RNA sequence enable SARS-CoV-2 to control host translation and escape anti-viral response

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion

Setu M. Vora et al.

Summary: A study has found that SARS-CoV-2 utilizes its nonstructural protein 1 (Nsp1) to suppress host protein synthesis, but targeting the SL1 region of the SARS-CoV-2 5' untranslated region (5' UTR) can evade Nsp1-mediated translational suppression and hinder viral replication. The findings provide a conservative therapeutic target for COVID-19.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Biochemistry & Molecular Biology

The key features of SARS-CoV-2 leader and NSP1 required for viral escape of NSP1-mediated repression

Lucija Bujanic et al.

Summary: The study reveals that the nonstructural protein 1 (NSP1) of SARS-CoV-2 inhibits host translation by blocking the mRNA entry tunnel on the ribosome, while viral mRNA overcomes this blockade. Specific residues within NSP1 and the viral leader sequence play critical roles in viral evasion.
Editorial Material Virology

mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses

Basil S. Karam et al.

Summary: The mTOR pathway plays a crucial role in viral infections, with inhibiting mTOR potentially leading to suppression of virus growth and replication. Recent studies suggest the modulation of mTOR in SARS-CoV-2 infection, highlighting the potential of mTOR inhibitors as an effective treatment for coronavirus diseases.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Multidisciplinary Sciences

Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation

Christopher P. Lapointe et al.

Summary: This study investigates the novel coronavirus protein NSP1, which is proposed to inhibit protein synthesis by binding directly to the ribosome. The researchers demonstrate that NSP1 inhibits translation of both human and virus messenger RNAs by specifically binding to the small ribosomal subunit and competing with RNA segments downstream of the start codon. Furthermore, they reveal that eukaryotic translation initiation factors modulate the interaction of NSP1 with ribosomal complexes in the absence of mRNA.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biochemistry & Molecular Biology

The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation

Antonin Tidu et al.

Summary: This study reveals how SARS-CoV-2 coronavirus evades NSP1 inhibition through the SL1 RNA hairpin, promoting viral translation and necessary for translation of subgenomic RNAs in the late phase of infection. Therapeutic strategies targeting SL1 may affect viral translation at both early and late stages of infection, making SL1 a potential Achilles heel of the virus.
Article Pharmacology & Pharmacy

The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo

Christin Mueller et al.

Summary: Rocaglate CR-31-B (-) exhibits potent antiviral activity against SARS-CoV-2, inhibiting viral replication and transmission. The drug showed significant antiviral effects in cell culture models, suggesting that it may be used as a first-line antiviral intervention strategy against novel RNA virus outbreaks.

ANTIVIRAL RESEARCH (2021)

Article Multidisciplinary Sciences

Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression

Ke Zhang et al.

Summary: The research shows that the virulence factor Nsp1 protein of SARS-CoV-2 interacts with the host messenger RNA (mRNA) export receptor heterodimer NXF1-NXT1, leading to retention of cellular mRNAs in the nucleus during infection. Increasing levels of NXF1 can rescue the Nsp1-mediated mRNA export block and inhibit SARS-CoV-2 infection. Antagonizing the inhibitory function of Nsp1 on mRNA export may represent a strategy to restore proper antiviral host gene expression in infected cells.

SCIENCE ADVANCES (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis

Yaara Finkel et al.

Summary: The study reveals that SARS-CoV-2 infection leads to a global reduction in translation and accelerated degradation of cytosolic cellular mRNAs. It also impairs the translation of transcripts induced in response to infection, probably mediated by inhibition of nuclear mRNA export.

NATURE (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition

Peter J. Mullen et al.

Summary: This study revealed that SARS-CoV-2 infection alters host cell metabolism by increasing glucose entry into the TCA cycle and reducing oxidative glutamine metabolism. Additionally, infection with SARS-CoV-2 activates mTORC1, and inhibiting mTORC1 can suppress viral replication in kidney epithelial cells and lung ALI cultures. These findings suggest that targeting mTORC1 could be a potential treatment strategy for COVID-19 patients.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Genes with 5′ terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein

Shilpa Rao et al.

Summary: Viruses rely on host translation machinery for survival and utilize Nsp1 to suppress host translation. The study reveals that a subset of human genes is preferentially translated in the presence of Nsp1, including genes related to viral pathogenicity. Additionally, the enrichment of 5' terminal oligo-pyrimidine tracts in these preferentially translated genes is uncovered.
Article Biochemistry & Molecular Biology

SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block

James M. Burke et al.

Summary: The study found that during SARS-CoV-2 infection, the biogenesis of IFN mRNAs is inhibited at multiple steps, including limited translocation of transcription factor IRF3 to the nucleus, localization of IFN mRNAs primarily at the site of transcription in most infected cells, and inhibition of nuclear-cytoplasmic transport. These results suggest that SARS-CoV-2 weakens the transcriptional induction of IFN genes through multiple mechanisms, inhibiting the production of interferon proteins in host cells and affecting the antiviral immune response.
Article Biochemistry & Molecular Biology

The Architecture of SARS-CoV-2 Transcriptome

Dongwan Kim et al.

Editorial Material Pharmacology & Pharmacy

An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?

Giuseppe Terrazzano et al.

FRONTIERS IN PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses

Abhik K. Banerjee et al.

Review Biochemistry & Molecular Biology

So close, no matter how far: multiple paths connecting transcription to mRNA translation in eukaryotes

Boris Slobodin et al.

EMBO REPORTS (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation

Katharina Schubert et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be

Giuseppina Mariano et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Article Biochemical Research Methods

UTAP: User-friendly Transcriptome Analysis Pipeline

Refael Kohen et al.

BMC BIOINFORMATICS (2019)

Article Biochemistry & Molecular Biology

HCV IRES Captures an Actively Translating 80S Ribosome

Takeshi Yokoyama et al.

MOLECULAR CELL (2019)

Article Pharmacology & Pharmacy

Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses

Christin Mueller et al.

ANTIVIRAL RESEARCH (2018)

Article Biochemical Research Methods

Purification of protein complexes of defined subunit stoichiometry using a set of orthogonal, tag-cleaving proteases

Steffen Frey et al.

JOURNAL OF CHROMATOGRAPHY A (2014)

Article Multidisciplinary Sciences

Massively Parallel Single-Cell RNA-Seq for Marker-Free Decomposition of Tissues into Cell Types

Diego Adhemar Jaitin et al.

SCIENCE (2014)

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

Editorial Material Microbiology

The Battle over mTOR: An Emerging Theatre in Host-Pathogen Immunity

Sunil Martin et al.

PLOS PATHOGENS (2012)

Article Multidisciplinary Sciences

A diverse range of gene products are effectors of the type I interferon antiviral response

John W. Schoggins et al.

NATURE (2011)

Article Biochemistry & Molecular Biology

A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein

Wataru Kamitani et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)

Article Multidisciplinary Sciences

Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation

Wataru Kamitani et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)